Common use of Termination by ▇▇▇▇▇▇▇ Without Cause Clause in Contracts

Termination by ▇▇▇▇▇▇▇ Without Cause. 12.2.1 ▇▇▇▇▇▇▇ has the right to terminate this Agreement in its entirety at any time after Completion of the phase 1b Clinical Trial and in its sole discretion on a Product-by-Product and country-by-country basis upon [*****] days advance written notice to ACI, except that ▇▇▇▇▇▇▇ will wind down any on-going Clinical Trial consistent with applicable law; 12.2.2 ▇▇▇▇▇▇▇ has the right to terminate this Agreement immediately in its sole discretion upon written notice to ACI if a Valid Safety Issue exists. The notice will provide sufficient information for ACI to confirm the existence of the Valid Safety Issue. A “Valid Safety Issue” means the ceasing of Development activities or withdrawal from any market as a result of reasonable concerns that the Product is unsafe for administration to humans. During the period of notice until the effective date of termination, [*****].

Appears in 3 contracts

Sources: License, Development and Commercialization Agreement (AC Immune SA), License, Development and Commercialization Agreement (AC Immune SA), License, Development and Commercialization Agreement (AC Immune SA)